Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2021
Insulin Receptor-Expressing T Cells Appear in Individuals at Risk for Type 1 Diabetes and Can Move into the Pancreas in C57BL/6 Transgenic MiceNeha Nandedkar-Kulkarni, Emily Esakov, Brigid Gregg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline dataJ A Cohen, P A Calabresi, S Chakraborty, et al.
Neurology|February 11, 2009
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MSJ A Cohen, P B Imrey, P A Calabresi, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Type 1 Diabetes Prevention: a systematic review of studies testing disease-modifying therapies and features linked to treatment responseJamie L Felton, Kurt J Griffin, Richard A Oram, et al.
Journal for Immunotherapy of Cancer|August 14, 2025
Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreasZoe Quandt, Arabella Young, Graham Larson Barlow, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Olivia Ballew, Chih-Chun Lee, et al.
Communications Medicine|October 4, 2023
Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic reviewJamie L Felton, Kurt J Griffin, Richard A Oram, et al.
Clinical Epigenetics|August 2, 2020
Circulating unmethylated CHTOP and INS DNA fragments provide evidence of possible islet cell death in youth with obesity and diabetesFarooq Syed, Sarah A Tersey, Jean-Valery Turatsinze, et al.
Ebiomedicine|May 7, 2025
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Olivia Ballew, Chih-Chun Lee, et al.
Communications Medicine|April 6, 2024
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic reviewJamie L Felton, Maria J Redondo, Richard A Oram, et al.
Pageof 6